Effect of oxaliplatin on NAD+ and NADP+ synthesis and salvage pathways

Effect of oxaliplatin on NAD+ and NADP+ synthesis and salvage pathways. The overall upregulation of the genes point to increased attempts to rebuild the cellular NAD+ pool. Abbreviations: CD38, NAD+ nucleosidase (Cd38); ENPP 1/2/3/4/5/6, ectonucleotide pyrophosphatase /phosphodiesterase 1–6 (Enpp1, Enpp2, Enpp3, Enpp4, Enpp5, Enpp6); NADK, NAD kinase (Nadk); NAMPT, nicotinamide phosphoribosyltransferase (Nampt); NNT, nicotinamide nucleotide transhydrogenase (Nnt); NRK2, nicotinamide riboside kinase 2 (Nmrk2); NT5E, ecto 5’-nucleotidase or CD73 (Nt5e); PNP, purine nucleoside phosphorylase (Pnp); ENT1, equilibrative nucleoside transporters 1/2/3 (Slc29a1, Slc29a2, Slc29a3); MCT1, monocarboxylic acid transporter 1 (Slc16a1); NADSYN1 (NAD Synthetase 1, Nadsyn1); NMNAT1/3 (nicotinamide nucleotide adenylyltransferases 1 and 3 (Nmnat1 and Nmnat3); NRK1 (nicotinamide riboside kinase 1 (Nmrk1); NUDT12; nudix hydrolase 12 (Nudt12); SIRT1/2/5/6 (sirtuins, Sirt1, Sirt2, Sirt5, and Sirt6); Slc25a51, mitochondrial nicotinamide adenine dinucleotide transporter (Slc25a51). ‘?’ - transporter for nicotinamide remains unidentified in heart. The pathway is derived from the KEGG database. Blue – upregulated genes, red downregulated genes, grey – not affected genes
Effect of oxaliplatin on NAD+ and NADP+ synthesis and salvage pathways

Publication

Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue (2023) Junwei Du, et al. bioRxiv. 2023 May 25;NA(NA). Figure: F13.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID